ArticleExperimental hematology & oncology2024

Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder.

Qiusui Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.